Want to see AU:XRF full AI Analyst Report?
Top Page
XRF Scientific Limited
(Sydney:XRF)
Select Model
Select Model
Rating:79Outperform
Price Target:
AU$2.00
â–˛(8.70% Upside)
Action:Upgraded
Date:08/19/26
The score is primarily driven by strong financial performance—robust margins, consistent earnings growth, and very low leverage. Technicals are supportive with price above major moving averages and positive MACD, though near-overbought RSI/Stoch readings add some caution. Valuation is the main offset, with a ~24.5 P/E and only a moderate ~2.39% dividend yield.
Positive Factors
Strong profitability
XRF’s high gross and operating margins indicate valuable products and services within laboratory workflows. Sustained profitability provides internal funding for product development, service capabilities and growth while offering resilience if demand moderates.
Negative Factors
Moderating revenue growth
Although revenue has more than doubled since 2021, recent growth has slowed materially from earlier expansion. A prolonged moderation could constrain operating leverage and make future earnings growth more dependent on market share gains or new product adoption.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong profitability
XRF’s high gross and operating margins indicate valuable products and services within laboratory workflows. Sustained profitability provides internal funding for product development, service capabilities and growth while offering resilience if demand moderates.
Read all positive factors
XRF Scientific Limited (XRF) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$260.10M
Dividend Yield2.48%
Average Volume (3M)240.16K
Price to Earnings (P/E)24.7
Beta (1Y)1.05
Revenue Growth8.35%
EPS Growth-0.81%
CountryAU
Employees48
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)0.07
Shares Outstanding143,703,300
10 Day Avg. Volume163,831
30 Day Avg. Volume240,164
Financial Highlights & Ratios
PEG Ratio-12.60
Price to Book (P/B)3.77
Price to Sales (P/S)3.90
P/FCF Ratio25.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.09
Revenue Forecast (FY)AU$70.70M
XRF Scientific Limited Business Overview & Revenue Model
Company Description
XRF Scientific Limited is a supplier to the scientific, analytical, construction materials, and mining sectors across Australia, Canada, and Europe. The company produces and sells precious metal items, specialized chemical compounds, and various i...
How the Company Makes Money
XRF makes money mainly by selling products and services used in laboratory sample preparation and analytical testing workflows. Key revenue streams include: (1) product sales of laboratory equipment and systems (e.g., sample preparation machinery ...
XRF Scientific Limited Financial Statement Overview
Summary
Income Statement
86
Very Positive
Balance Sheet
90
Very Positive
Cash Flow
78
Positive
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 64.13M | 59.45M | 59.84M | 55.17M | 40.01M |
| Gross Profit | 30.10M | 28.79M | 26.27M | 22.00M | 16.46M |
| EBITDA | 18.72M | 15.63M | 15.32M | 13.22M | 9.44M |
| Net Income | 10.49M | 10.38M | 8.89M | 7.69M | 6.08M |
Balance Sheet | |||||
| Total Assets | 78.65M | 72.79M | 68.23M | 65.55M | 55.56M |
| Cash, Cash Equivalents and Short-Term Investments | 9.46M | 12.23M | 12.05M | 10.40M | 6.65M |
| Total Debt | 2.34M | 4.41M | 3.38M | 4.31M | 3.51M |
| Total Liabilities | 12.26M | 12.62M | 12.69M | 15.97M | 12.21M |
| Stockholders Equity | 66.40M | 60.17M | 54.89M | 49.25M | 43.48M |
Cash Flow | |||||
| Free Cash Flow | 9.69M | 8.39M | 6.45M | 7.63M | 2.63M |
| Operating Cash Flow | 11.39M | 10.14M | 8.09M | 8.42M | 3.15M |
| Investing Cash Flow | -8.17M | -2.21M | -1.64M | -782.43K | -1.11M |
| Financing Cash Flow | -5.99M | -7.75M | -4.80M | -3.88M | -648.95K |
XRF Scientific Limited Technical Analysis
Neutral
1.84
Price Trends
1.77
Positive
1.80
Positive
1.86
Negative
Market Momentum
0.02
Positive
51.28
Neutral
4.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:XRF, the sentiment is Neutral. The current price of 1.84 is above the 20-day moving average (MA) of 1.83, above the 50-day MA of 1.77, and below the 200-day MA of 1.86, indicating a neutral trend. The MACD of 0.02 indicates Positive momentum. The RSI at 51.28 is Neutral, neither overbought nor oversold. The STOCH value of 4.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:XRF.
XRF Scientific Limited Peers Comparison
UnderperformOutperform
Sector (63)
AU:XRF
XRF Scientific Limited
1.82
-0.38
-17.12%
AU:IMD
Imdex Ltd
3.51
0.51
17.08%
XRF Scientific Limited Corporate Events
XRF Scientific Files Updated Corporate Governance Statement and Appendix 4G
Aug 17, 2026
XRF Scientific Limited has lodged its annual corporate governance disclosures with the ASX, confirming that its corporate governance statement for the year ended 30 June 2026 is available on its website and is current as of 17 August 2026. The fil...
XRF Scientific Declares Full-Year Dividend of 4.5 Cents per Share
Aug 17, 2026
XRF Scientific Limited has declared an ordinary dividend of AUD 0.045 per share, relating to the 12-month period ending 30 June 2026, for its fully paid ordinary shares. The stock will trade ex-dividend on 10 September 2026, with a record date of ...
XRF Scientific posts record year as global growth and new products drive earnings
Aug 17, 2026
XRF Scientific has reported a record full-year result to June 2026, with revenue rising 8% to $64.4 million and adjusted profit before tax up 10% to $16.1 million, driven by strong demand from mining and industrial customers and growing internatio...
XRF Scientific Releases 2026 Annual Financial Report
Aug 17, 2026
XRF Scientific Limited has released its annual financial report for the year ended 30 June 2026, outlining its audited results and key corporate disclosures. The document includes the chairman’s letter, directors’ report, consolidated ...
XRF Scientific Posts Steady Profit and Maintains Dividend for FY2026
Aug 17, 2026
XRF Scientific Limited reported an 8% rise in revenue to $64.4 million for the year ended 30 June 2026, with net profit attributable to members edging up 1% to $10.49 million. The modest earnings growth, combined with slightly lower net tangible a...
XRF Scientific Director Restructures Shareholdings via Off‑Market Transfer
Jun 23, 2026
XRF Scientific has reported a change in the shareholdings of director David Brown, reflecting an off‑market transfer between his direct holding and his interest via the Pandora Super (WA) Pty Ltd, as trustee for the Pandora Super Fund. Follo...
XRF Scientific Showcases Broad Role in Sample Preparation and Analysis Technology
Jun 8, 2026
XRF Scientific Limited highlights its role as a provider of specialised sample preparation and chemical analysis technology used across a broad range of mineral commodities and industrial materials. The company’s solutions support key analyt...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.